| Característica |
Objectiu de la convocatòria
This competitive program seeks to support global research that helps to address Ulcerative Colitis data gaps and advances the understanding of etrasimod and / or tofacitinib role in the treatment landscape.
|
Característiques principals
Potential applicants are encouraged to identify and address the data gaps and advances understanding the role of etrasimod and tofacitinib in UC treatment landscape. This may include:
Exploration for optimal ultrasonographic markers
Evaluation of UC extraintestinal manifestations
Evaluation in specific subgroups of special interest
Evaluation of advanced therapy sequencing strategy
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
• Carol Barnwell, cbarnwell@researchmar.net Ext.: 1670
• Marta López, mlopez4@researchmar.net Ext.: 1576
|
Convocatòria (URL)
https://cdn.pfizer.com/pfizercom/2024-06/GMG-2024-I&I-G-IDM-ResearchUlcerativeColitis(UC)RES.pdf?VersionId=nykqfoIhG6BWrwtnzLK2kaVKF3yLxLko
|
Requisits
The institution and Principal Investigator (PI) must be based in one of the eligible countries noted
above.
Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an
independent group of physicians not affiliated with a hospital, academic institution, or professional
society).
If the project involves multiple departments within an institution and/or between different institutions /
organizations / associations, all institutions must have a relevant role and the requesting organization
must have a key role in the project.
The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing
degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research
coordinator).
The PI must be an employee or contractor of the requesting organization.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We
strongly recommend that applicants confirm this with their organization or institution prior to
submitting an application. Grants awarded to organizations that are subsequently found to be unable
to accept funding directly from Pfizer Inc. may be subject to rescission.
|
Dotació
$200,000
|
Durada
maximum of 18 months
|